Clinical effects and bronchoalveolar transfer of levofloxacin in patients with community-acquired pneumonia.
Lin
Y
Y
Department of Respiratory Diseases, PUMC Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
Su
W
W
Xu
Z
Z
Bai
Y
Y
D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000382:microbiology; D005260:Female; D006801:Humans; D064704:Levofloxacin; D008297:Male; D008875:Middle Aged; D015242:Ofloxacin / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D018410:Pneumonia, Bacterial / Q000188:drug therapy*; D013997:Time Factors; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D064704:Levofloxacin; D015242:Ofloxacin